Holdings (as at 2026-10-02)
Percentage of net assets may not equal 100%
Security Name % of Net Assets
Natera, Inc. 3.37%
Guardant Health, Inc. 2.64%
Universal Health Services, Inc. (Class B) 2.63%
Regeneron Pharmaceuticals, Inc. 2.62%
Pfizer Inc. 2.57%
Solventum Corporation 2.53%
Halozyme Therapeutics, Inc. 2.33%
Tenet Healthcare Corporation 2.30%
Zimmer Biomet Holdings, Inc. 2.28%
Boston Scientific Corporation 2.22%
Corcept Therapeutics Inc. 2.22%
Centene Corporation 2.18%
The Cigna Group 2.18%
Globus Medical, Inc. (Class A) 2.13%
Medline Inc. (Class A) 2.01%
Encompass Health Corporation 1.97%
QIAGEN N.V. 1.90%
ResMed Inc. 1.87%
Medtronic Plc 1.83%
Doximity, Inc. (Class A) 1.80%
DaVita Inc. 1.79%
Incyte Corporation 1.69%
Elevance Health Inc. 1.66%
United Therapeutics Corporation 1.66%
Axsome Therapeutics, Inc. 1.63%
Zoetis Inc. 1.61%
Eli Lilly and Company 1.59%
Becton, Dickinson and Company 1.56%
Gilead Sciences, Inc. 1.53%
Medpace Holdings, Inc. 1.51%
Viatris Inc. 1.48%
Quest Diagnostics Incorporated 1.47%
Revolution Medicines, Inc. 1.47%
Labcorp Holdings Inc. 1.47%
Exelixis, Inc. 1.43%
Bristol-Myers Squibb Company 1.42%
Ascendis Pharma A/S 1.42%
Neurocrine Biosciences, Inc. 1.41%
Biogen Inc. 1.36%
GE HealthCare Technologies Inc. 1.34%
Steris Plc 1.32%
Arrowhead Pharmaceuticals, Inc. 1.31%
Veeva Systems Inc. (Class A) 1.28%
IQVIA Holdings Inc. 1.11%
Tempus AI, Inc. (Class A) 1.10%
Thermo Fisher Scientific Inc. 1.09%
Agilent Technologies, Inc. 1.05%
HCA Healthcare, Inc. 0.91%
Chemed Corporation 0.90%
Abbott Laboratories 0.89%
AbbVie Inc. 0.87%
Vertex Pharmaceuticals Incorporated 0.85%
Henry Schein, Inc. 0.84%
Organon & Co. 0.84%
Madrigal Pharmaceuticals, Inc. 0.77%
BridgeBio Pharma, Inc. 0.75%
Ionis Pharmaceuticals, Inc. 0.73%
Align Technology, Inc. 0.71%
Illumina, Inc. 0.65%
Revvity, Inc. 0.57%
DexCom, Inc. 0.53%
Bio-Rad Laboratories, Inc. (Class A) 0.52%
Merck & Co., Inc. 0.47%
Danaher Corporation 0.47%
Amgen Inc. 0.46%
The Ensign Group, Inc. 0.44%
West Pharmaceutical Services, Inc. 0.43%
Johnson & Johnson 0.42%
BioMarin Pharmaceutical Inc. 0.42%
IDEXX Laboratories, Inc. 0.41%
Envista Holdings Corporation 0.37%
Stryker Corporation 0.36%
The Cooper Companies, Inc. 0.33%

Holdings are subject to change.

Commissions, management fees and expenses all may be associated with Exchange-Traded Fund investments. Please carefully read the prospectus of the fund before investing. Exchange-Traded funds are not guaranteed, their values change frequently and past performance may not be repeated.